Novel Methods for Disinfection of Prion-Contaminated Medical Devices
Lancet 364:521-526, Fichet,G.,et al, 2004
Extraneural Pathologic Prion Protein in Sporadic Creutzfeldt-Jakob Disease
NEJM 349:1812-1820, Glatzel,M.,et al, 2003
Surgical Treatment and Risk of Sporadic Creutzfeldt-Jakob Disease:A Case-Control Study
Lancet 353:693-697, Collins,S.,et al, 1999
Transmission ofr Creutzfeldt-Jakob Disease in Corneal Grafts, Exclusion Criteria Ensure Risk is Small
BMJ 315:1553-1554, Allan,B.&Tuft,S., 1997
Potential Transmission of BSE via Medicinal products
BMJ 312:988-989, Wickham,E.A., 1996
Creutzfeldt-Jakob Disease from Contaminated Growth Hormone Extracts in France
Neurol 47:690-695, Billette de Villemeur,T.,et al, 1996
"Friendly Fire"in Medicine:Hormones, Homografts, and Creutzfeldt-Jakob Disease
Lancet 340:24-27, Brown,P.,et al, 1992
Creutzfeldt-Jakob Disease in a Patient with a Cadaveric Dural Graft
Neurol 41:940-941, Miyashita,K.,et al, 1991
Differential Diagnosis of Bilateral Abnormalities of the Basal Ganglia and Thalamus
RadioGraphics 31:5-30, Hegde,A.N.,et al, 2011
Iatrogenic Creutzfeldt-Jakob Disease: The Waning of an Era
Neurol 67:389-393, Brown,P.,et al, 2006
Clinical Presentation and Pre-Mortem Diagnosis of Variant Creutzfeldt-Jakob Disease Associated With Blood Transfusion: A Case Report
Lancet 368:2061-2067, Wroe,S.J.,et al, 2006
Possible Transmission of Variant Creutzfeldt-Jakob Disease by Blood Transfusion
Lancet 363:417-421,411, Llewelyn,C.A.,et al, 2004
Preclinical vCJD After Blood Transfusion in a PRNP Codon 129 Heterozygous Patient
Lancet 364:527-529, Peden,A.H.,et al, 2004
Sporadic Creutzfeldt-Jakob Disease and Surgery
Neurol 59:543-548, Ward,H.J.T.,et al, 2002
14-3-3 Protein Cerebrspinal Fluid Detection in Human Growth Hormone-Treated Creutzfeldt-Jakob Disease Patients
Ann Neurol 49:257-260, Brandel,J.,et al, 2001
Iatrogenic Creutzfeldt-Jakob Disease at the Millenium
Neurol 55:1075-1081, Brown,P.,et al, 2000
Creutzfeldt-Jakob Disease and Related Transmissible Spongiform Encephalopathies
NEJM 339:1994-2004, Johnson,R.T. & Gibbs,Jr.,C.J., 1998
Creutzfeldt-Jakob Disease after Extracranial Dura Mater Embolization for a Nasopharyngeal Angiofibroma
Neurol 48:1451-1453, Antoine,J.C.,et al, 1997
Creutzfeldt-Jakob Dis after Embolization of Intercostal Arteries with Cadaveric Dura Suggest a Syst Trans of Prion Agent
Neurol 48:1470-1471, Defebvre,L.,et al, 1997
Transmissible Spongiform Encephalopathies
NEJM 337:1821-1828, Haywood,A.M., 1997
Iatrogenic Creutzfeldt-Jakob Disease:An Example of the Interplay Between Ancient Genes and Modern Medicine
Neurol 44:291-293, Brown,P.,et al, 1994
Drug Induced Creutzfeldt-Jakob Like Syndrome
J Psychiatr Neurosci 17:103-105, Finelli,P.F., 1992
Creutzfeldt-Jakob Disease in a Recipient of Human Pituitary-Derived Gonadotrophin:A Second Case
JNNP 55:1094-1095, Cochius,J.I.,et al, 1992
Creutzfeldt-Jakob Disease in Pituitary Growth Hormone Recipients in the United States
JAMA 265:880-884, Fradkin,J.E.,et al, 1991
Genetic Predisposition to Iatrogenic Creutzfeldt-Jakob Disease
Lancet 337:1441-1442, Collinge,J.,et al, 1991
Mortality, Neoplasia, & Creutzfeldt-Jakob Disease in Patients Treated with Human Pituitary Growth Hormone in the UK
BMJ 302:824-828, Buchanan,C.R.,et al, 1991
The Spongiform Encephalopathies, Editorial
JNNP 54:761-763, Will,R.G., 1991
Human Growth Hormone Therapy & Creutzfeldt-Jakob Disease:A Drama in Three Acts
Pediatrics 81:85-92, Brown,P., 1988
The Decline and Fall of Creutzfeldt-Jakob Disease Associated with Human Growth Hormone Therapy
Neurol 38:1135-1137, Brown,P., 1988
A Creutzfeldt-Jakob Like Syndrome Due to Lithium Toxicity
JNNP 51:120-123, Smith,S.J.M.&Kocen,R.S., 1988
Iatrogenic Creutzfeldt-Jakob Disease
Neurol 37:1520-1522, Rappaport,E.B., 1987
Creutzfeldt-Jakob Disease after Administration of Human Growth Hormone
Lancet 2:244-246, Powell-Jackson,J.,et al, 1985
Neurovascular Complications of Iatrogenic Fusarium solani Meningitis
NEJM 390:522-529, Strong, N.,et al, 2024
Iatrogenic Cerebral Amyloid Angiopaty Post Neurosurgery:Frequency, Clinical Profile, Radiological Features, and Outcome
Stroke 54:1214-1223, 1224, Kaushik,K.,et al, 2023
New-Onset Diplopia and Headache in a Patient with Metastatic Breast Cancer
Neurol 100:927-931, Rizzo,S.A.,et al, 2023
Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023
Intracerebral Haemorrhage Caused by Iatrogenic Cerebral Amyloid Angiopathy in a Patient with a History of Neurosurgery 35 Years Earlier
Lancet 402:11, Fandler-Hofler,et al, 2023
Blook Transfusion and Brain Amyloidosis, Should We Be Worried?
JAMA 330:921-922, Greenberg,S.M., 2023
Severe Amyloid-Related Imaging Abnormalities After Anti-B-Amyloid Monoclonal Antibody Treatment
Neurol 101:1079-1080, Bonami,S.,et al, 2023
Cholesterol Embolization Syndrome after Carotid-Artery Stenting
NEJM 386:1265, Wang, W. & Cai, J., 2022
Risk of First Ischaemic Stroke and Use of Antidopaminergic Antiemetics: Nationwide Case-Time-Control Study
BMJ 376:e061921, Benard-Laribiere, A.,et al, 2022
Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side Effects
JENDSO 6:1-7, Hamidi, S.,et al, 2022
Atypical Posterior Reversible Encephalopathy Syndrome Associated with Lenvatinib Therapy in a Patient with Metastatic Thyroid-Cancer
Cancer Reports doi:10.1002/cnr2.1605, Abhishek, M.,et al, 2022
A 48-Year-Old Woman with 6 Months of Vivid Visual Hallucinations
Neurol 99:166-171, Kizza, J.,et al, 2022
Reversible Parkinsonism Caused by Lumboperitoneal Shunt Overdrainage
Neurol 99:486-488, Takeuchi, H.,et al, 2022
Imaging Findings in Children Presenting with CNS Nelarabine Toxicity
AJNR 43:1802-1809, Serrallach,B.L.,et al, 2022
Chorioretinopathy After Corticosteroid Treatment for Optic Neuritis
Neurol 96:e305-e306, Ling, J. and Micieli, J.A., 2021
Clinicopathologic Conference, Disseminated Mycobacterium Bovis Infection
NEJM 384:651-662, Case 5-2021, 2021
ANA Investigates: Neurological Complications of Covid-19 Vaccines
Ann Neurol 89:856-857, Goss, A.L.,et al, 2021